Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Comparing Outcomes between Liposomal Daunorubicin/Cytarabine (CPX-351) and HMA+Venetoclax As Frontline Therapy in Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 32.

https://doi.org/10.1182/blood-2021-145947

Published: 2021

Journal Articles

Timing of Daratumumab Administered Pre-Mobilization in Multiple Myeloma Impacts Pre-Harvest Peripheral Blood CD34+ Cell Counts and Plerixafor Use

Danny Luan, MPH, Paul J Christos, Dr.P.H., M.S., Michael Ancharski, MLS(ASCP), Danielle Guarneri, BS, CCRP, Roger Pearse, MD PhD, Adriana C Rossi, MD MSc, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Adrienne A. Phillips, MD MPH, Jingmei Hsu, MD, Ljiljana V. Vasovic, MD, Yen-Michael S. Hsu, MD PhD, Koen van Besien, MD PhD, Ruben Niesvizky, MD, Cara A. Rosenbaum, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-140811

Published: 2020

Journal Articles

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma (MCL): 7-Year Analysis from a Multi-Center Phase II Study

Samuel Yamshon, MD, Peter Martin, FRCPC, MD MS, Bijal Shah, MD, Stephen J. Schuster, MD, Paul J Christos, Dr.P.H., M.S., Amelyn Rodriguez, BSN, RN, OCN, Sonali M. Smith, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Sarah C. Rutherford, MD, John N. Allan, MD, John P. Leonard, MD, Jia Ruan, MD PhD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-138731

Published: 2020

Journal Articles

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Ahmed Toure, BA, Yiyuan Wu, MS, Paul J Christos, Dr.P.H., M.S., Peter Martin, FRCPC, MD MS

Blood (2019) 134 (Supplement_1): 2205.

https://doi.org/10.1182/blood-2019-131567

Published: 2019

Journal Articles

Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple Myeloma

Cara A. Rosenbaum, MD, Danny Luan, BS, MPH, Paul J Christos, Dr.P.H., M.S., Roger Pearse, MD PhD, Danielle Guarneri, BS, CCRP, Morton Coleman, MD, Koen Van Besien, MD PhD, Ruben Niesvizky, MD

Blood (2019) 134 (Supplement_1): 2026.

https://doi.org/10.1182/blood-2019-127710

Published: 2019

Journal Articles

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Ivan Bascon, Molecular Bioscience and Biotechnology, B.S., Paul J Christos, Dr.P.H., M.S., Maria Teresa De Sancho, MD MSc

Blood (2019) 134 (Supplement_1): 3657.

https://doi.org/10.1182/blood-2019-132248

Published: 2019

Journal Articles

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Pinkal Desai, MDMPH, Samuel Handelman, PhD, Alan Wu, MPH, Paul J Christos, Dr.P.H., M.S., Sangmin Lee, MD, Michael B. Samuel, MD, Ellen K. Ritchie, MD, Monica L. Guzman, PhD, Rebecca Jackson, Duane C. Hassane, PhD, Joann Manson, Alexander Reiner, MD, Michael S. Simon, MDMPH, Gail J. Roboz, MD

Blood (2019) 134 (Supplement_1): 1199.

https://doi.org/10.1182/blood-2019-131862

Published: 2019

Journal Articles

Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis

Danny Luan, BS, MPH, Koen Van Besien, MD PhD, Paul J Christos, Dr.P.H., M.S., Roger Pearse, MD PhD, Danielle Guarneri, BS, CCRP, Morton Coleman, MD, Ruben Niesvizky, MD, Cara A. Rosenbaum, MD

Blood (2019) 134 (Supplement_1): 4579.

https://doi.org/10.1182/blood-2019-127723

Published: 2019

Journal Articles

Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide

Samuel Yamshon, MD, Michelle Demetres, BA, Hoda Hammad, MS, MPH, Paul J Christos, Dr.P.H., M.S., John P. Leonard, MD, Jia Ruan, MD PhD

Blood (2017) 130 (Supplement 1): 221.

https://doi.org/10.1182/blood.V130.Suppl_1.221.677

Published: 2017

Journal Articles

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Alexandra Gomez-Arteaga, MD, Tomer M Mark, MDMSc, Danielle Guarneri, Paul J Christos, Dr.P.H., M.S., Usama Gergis, MD, June Greenberg, RN, Jingmei Hsu, MD PhD, Sebastian A. Mayer, MD, Ruben Niesvizky, MD, Roger Pearse, MD PhD, Adrienne A. Phillips, MD MPH, Adriana C. Rossi, MDMSc, Morton Coleman, MD, Koen Van Besien, MD PhD, Tsiporah B. Shore, MD

Blood (2017) 130 (Supplement 1): 4546.

https://doi.org/10.1182/blood.V130.Suppl_1.4546.4546

Published: 2017

Journal Articles

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma: 5-Year Follow-up and Correlative Analysis from a Multi-Center Phase II Study

Jia Ruan, MD PhD, Peter Martin, FRCPC, MD MS, Paul J Christos, Dr.P.H., M.S., Leandro Cerchietti, MD, Bijal D. Shah, MD, Stephen J. Schuster, MD, Wayne Tam, MD PhD, Amelyn Rodriguez, BSN, RN, OCN, David Hyman, Maria Nieves Calvo Vidal, PhD, Lidia Roman Gonzalez, Sonali M. Smith, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Morton Coleman, MD, John P. Leonard, MD

Blood (2017) 130 (Supplement 1): 154.

https://doi.org/10.1182/blood.V130.Suppl_1.154.154

Published: 2017

Journal Articles

Combining Decitabine With Plerixafor Yields a High Response Rate In Newly Diagnosed Older Patients With AML

Gail J. Roboz, MD, Joseph M. Scandura, MD, PhD, Ellen Ritchie, MD, Yulia Dault, RN, Linda Lam, Wen Xie, Hsiao-Ting Hsu, Danielle Marshall, Paul J Christos, Cindy Ippoliti, Eric J. Feldman, MD, Monica L. Guzman, PhD

Blood (2013) 122 (21): 621.

https://doi.org/10.1182/blood.V122.21.621.621

Published: 2013

Journal Articles

DNA Methylation Profiling Predicts Clinical Outcomes and Reveals Unique Insights Into the Molecular Complexity of Acute Myeloid Leukemia.

Maria E Figueroa, MD, Sanne Lugthart, MD, Yushan Li, Claudia Erpelinck-Verschueren, Xutao Deng, Paul J. Christos, PhD, Elizabeth Schifano, Jim Booth, Lucy Skrabanek, Fabien Campagne, Madhu Mazumdar, PhD, John Greally, MB, PhD, Peter Valk, Bob Lowenberg, MD, PhD, Ruud Delwel, PhD, Ari Melnick

Blood (2009) 114 (22): 707.

https://doi.org/10.1182/blood.V114.22.707.707

Published: 2009

Journal Articles

Evaluation of Alternative, “Low-intensity” Induction Regimens in Elderly Adults with Acute Myeloid Leukemia (AML).

Eric J. Feldman, MD, Ellen Ritchie, MD, Usama Gergis, MD, Sebastian Mayer, MD, Joseph M. Scandura, MD, PhD, Paul J. Christos, PhD, Usama Wissa, MD, Gail J. Roboz, MD

Blood (2009) 114 (22): 2066.

https://doi.org/10.1182/blood.V114.22.2066.2066

Published: 2009

Journal Articles

Decrease in JAK2 V617F Allele Burden is Not a Prerequisite to Clinical Response in Patients with Polycythemia Vera (PV).

Richard T. Silver, MD, Katherine Vandris, Joshua J. Goldman, Fernando Adriano, Y. Lynn Wang, MD, PhD, Amy V. Jones, Paul J. Christos, PhD, N. C.P. Cross, PhD

Blood (2009) 114 (22): 1908.

https://doi.org/10.1182/blood.V114.22.1908.1908

Published: 2009

Journal Articles

Epigenetic Signatures Identify New Clinically Relevant Subtypes and Define Gene Regulatory Patterns in Patients with Acute Myeloid Leukemia (AML)

Maria E Figueroa, MD, Sanne Lugthart, MD, Yushan Li, Claudia Erpelinck-Verschueren, Paul J Christos, MS, MPH, Madhu Mazumdar, PhD, Bob Löwenberg, MD, PhD, John Greally, MB, PhD, Peter JM Valk, PhD, Ruud Delwel, PhD, Ari Melnick, MD

Blood (2008) 112 (11): 756.

https://doi.org/10.1182/blood.V112.11.756.756

Published: 2008

Journal Articles

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Blood (2008) 111 (3): 1101–1109.

https://doi.org/10.1182/blood-2007-05-090258

Published: 2008

Includes: Supplemental data

Journal Articles

Atypical Serum Immunofixation Pattern (ASIP) Development during Induction Therapy with BiRD for Newly Diagnosed Multiple Myeloma Correlates with a High Rate of Complete Remission.

Tomer Mark, MD, David Jayabalan, Roger N. Pearse, MD/PhD, Y. Lynn Wang, PhD, Richard Lent, MD, Paul J. Christos, MPH, Joong W. Lee, PhD, Yashpal P. Agrawal, MD/PhD, Susan Matthews, PhD, Scott Ely, MD, Madhu Mazumdar, PhD, Ethel Cesarman, MD, April Rambo, RN, John P. Leonard, MD, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD

Blood (2007) 110 (11): 2737.

https://doi.org/10.1182/blood.V110.11.2737.2737

Published: 2007

Journal Articles

Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.

Tomer Mark, MD, David Jayabalan, Roger N. Pearse, MD/PhD, Jessica Stern, Jessica Furst, April Rambo, RN, John Harpel, MD/PhD, Tsiporah Shore, MD, Michael Schuster, MD, John P. Leonard, MD, Paul J. Christos, MPH, Morton Coleman, MD, Ruben Niesvizky, MD

Blood (2007) 110 (11): 3024.

https://doi.org/10.1182/blood.V110.11.3024.3024

Published: 2007

Journal Articles

JAK2 V617F Mutational Load in Patients with Polycythemia Vera (PV) Measured by Peripheral Blood DNA Is Associated with Disease Severity.

Richard T. Silver, MD, Katherine Vandris, Y. Lynn Wang, M.D., Ph.D., Paul J. Christos, M.P.H., M.S., Fernando Adriano, R.N., B.S.N., O.C.N., Amy V. Jones, Nicholas C.P. Cross, Ph.D.

Blood (2007) 110 (11): 2530.

https://doi.org/10.1182/blood.V110.11.2530.2530

Published: 2007

NARROW

Comparing Outcomes between Liposomal Daunorubicin/Cytarabine (CPX-351) and HMA+Venetoclax As Frontline Therapy in Acute Myeloid Leukemia

Timing of Daratumumab Administered Pre-Mobilization in Multiple Myeloma Impacts Pre-Harvest Peripheral Blood CD34+ Cell Counts and Plerixafor Use

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma (MCL): 7-Year Analysis from a Multi-Center Phase II Study

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple Myeloma

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study

Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis

Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Initial Treatment with Lenalidomide Plus Rituximab for Mantle Cell Lymphoma: 5-Year Follow-up and Correlative Analysis from a Multi-Center Phase II Study

Combining Decitabine With Plerixafor Yields a High Response Rate In Newly Diagnosed Older Patients With AML

DNA Methylation Profiling Predicts Clinical Outcomes and Reveals Unique Insights Into the Molecular Complexity of Acute Myeloid Leukemia.

Evaluation of Alternative, “Low-intensity” Induction Regimens in Elderly Adults with Acute Myeloid Leukemia (AML).

Decrease in JAK2 V617F Allele Burden is Not a Prerequisite to Clinical Response in Patients with Polycythemia Vera (PV).

Epigenetic Signatures Identify New Clinically Relevant Subtypes and Define Gene Regulatory Patterns in Patients with Acute Myeloid Leukemia (AML)

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Atypical Serum Immunofixation Pattern (ASIP) Development during Induction Therapy with BiRD for Newly Diagnosed Multiple Myeloma Correlates with a High Rate of Complete Remission.

Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.

JAK2 V617F Mutational Load in Patients with Polycythemia Vera (PV) Measured by Peripheral Blood DNA Is Associated with Disease Severity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only